Navigation Links
iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
Date:6/11/2009

SOUTH SAN FRANCISCO, Calif., June 11 /PRNewswire/ -- iZumi Bio, Inc., a biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient cells, today announced the appointment of Corey S. Goodman, Ph.D., to the company's board of directors and scientific advisory board. Dr. Goodman most recently served as president of Pfizer's Biotherapeutics and Bioinnovation Center.

"Dr. Goodman's drug discovery and development expertise will be instrumental as we apply our iPS technology to the development of new therapeutics for unmet medical needs. We will look to Dr. Goodman's extensive knowledge and leadership in neurology to help advance our proprietary neurodegenerative programs in amyotrophic lateral sclerosis, spinal muscular atrophy and Parkinson's disease," said John P. Walker, chief executive officer of iZumi. "Over the next few months, we intend to build a world-renowned scientific advisory board, in order to provide guidance and scientific direction for both our proprietary neurodegenerative programs and for additional disease areas, such as metabolic disease, that we plan to pursue through partnerships."

"iZumi's approach opens a new door for stem cell research and its application to therapeutic discovery, and I am excited to work with the company to identify new treatment options for patients suffering from difficult-to-treat conditions including neurodegenerative diseases," said Dr. Goodman.

Prior to joining Pfizer, Dr. Goodman served as the president and chief executive officer of Renovis from 2001 until 2007, when the company merged with Evotec. He has advised numerous biotechnology companies, and co-founded two companies, including Exelixis and Renovis.

Dr. Goodman was a professor at Stanford University and the '/>"/>

SOURCE iZumi Bio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development
2. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
3. iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
4. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
5. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
6. Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
7. PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
8. SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
9. China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program
10. Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer
11. Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Scientists at USC have developed a new microscopy ... in living animals at higher-than-ever resolution. , Dubbed ... allows imaging resolutions that are an order of ... insights into the behavior of biomolecules at the ... Sept. 18 by Nature Communications , the ...
(Date:9/18/2014)... Silicon-valley Electronic Data Capture (EDC) provider ... , the latest addition to Clinovo’s CRO Partnership Program. ... (CRO) Program, Clinovo further expands its global reach to ... training, we are now able to build studies on ... can also rely on Clinovo to fully support the ...
(Date:9/18/2014)... New York, NY (PRWEB) September 18, 2014 ... has completed negotiations with Salem Realty Group and has ... and development space within the Salem Executive Complex adjacent ... cutting ceremony was held on Friday September 5th. Whitehouse ... to refit the entire space specifically for package testing. ...
(Date:9/17/2014)... Sept. 17, 2014 The global consumption of squalene ... Squalene is a natural skin-identical chemical that finds applications in ... food supplements, pharmaceuticals, and in other applications like high grade ... has a few major players and is regionally segregated. Sophim ... Liver Oil Co. Ltd. ( Japan ), SeaDragon ...
Breaking Biology Technology:Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3
... Third Quarter Highlights Recognized ... from Department of Defense (DoD) for nerve agent medical countermeasure ... profit split on worldwide sales of ST-246 and related products ... Completed 1500L commercial scale-up and first cGMP manufacturing run ...
... 8, 2011 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... today announced financial results for the third quarter of 2011. ... a net loss of $4.6 million, or $0.10 per share, ... $0.31 per share, for the third quarter of 2010. As ...
... for data-intensive biomedical and genetic research -- is ... team of researchers including Anton Nekrutenko, an associate ... State University; Kateryna Makova, an associate professor of ... Emory University, developed the new technology, which will ...
Cached Biology Technology:PharmAthene Reports Third Quarter 2011 Financial and Operating Results 2PharmAthene Reports Third Quarter 2011 Financial and Operating Results 3PharmAthene Reports Third Quarter 2011 Financial and Operating Results 4PharmAthene Reports Third Quarter 2011 Financial and Operating Results 5PharmAthene Reports Third Quarter 2011 Financial and Operating Results 6PharmAthene Reports Third Quarter 2011 Financial and Operating Results 7PharmAthene Reports Third Quarter 2011 Financial and Operating Results 8Orexigen® Therapeutics Reports Third Quarter Financial Results 2Orexigen® Therapeutics Reports Third Quarter Financial Results 3Orexigen® Therapeutics Reports Third Quarter Financial Results 4Orexigen® Therapeutics Reports Third Quarter Financial Results 5Galaxy DNA-analysis software is now available 'in the cloud' 2Galaxy DNA-analysis software is now available 'in the cloud' 3
(Date:9/17/2014)... Informatics at IMIM (Hospital del Mar Medical Research Institute) ... recently published a study in eLife showing ... in the evolution of new proteins, some of which ... Ribosomes produce proteins from the instructions found in an ... is RNA containing information for the synthesis of proteins, ...
(Date:9/17/2014)... Mich. Mutations in the human retinoblastoma protein gene ... State University scientists have turned to fruit fly eyes ... , In a paper featured on the cover ... Biological Chemistry , Michigan State University researchers provide the ... to those present in the human cancer gene, said ...
(Date:9/17/2014)... decades of decline, grasses have returned to some once-denuded ... marsh in those places seems healthy again, but a ... the marsh coastal protection remains diminished. , ... hasn,t come back," said ecologist Mark Bertness, professor of ... in the journal Biological Conservation . "The metric ...
Breaking Biology News(10 mins):Parts of genome without a known function may play a key role in the birth of new proteins 2Abnormal properties of cancer protein revealed in fly eyes 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
... In order for a gene to create a protein, ... as messenger RNA. These RNA molecules are the instruction manuals ... how to build a protein. A few years ago, scientists ... metabolic products (metabolites) can bind to. In doing so, they ...
... New drugs that are helping fight a multi-front war on ... of Georgia researchers said. Cancer and cardiovascular disease, both ... shock protein 90 inhibitors as a treatment could become additional ... Biology Center. "I think hsp90 inhibitors may be some ...
... David L. Rimoin, MD, PhD, FACMG of Cedars-Sinai ... College of Medical Genetics Foundation (ACMGF) second annual Lifetime ... Dr. Rimoin was recognized for his decades of contributions ... and heritable disorders of connective tissue, and for helping ...
Cached Biology News:Genes under control 2New cancer therapy may fight cardiovascular disease 2Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award 2Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award 3
... The TUNEL-based assay kit provides complete ... cells for convenient detection of DNA ... sections. The incorporation of BrdU in ... biotinylated or digoxigenylated methods. Results can ...
... ergonomic microscopes are now available in digital ... DM-BA200 comes packed with Motic's patented Colour ... plug and play digital image capture head. ... a reversed quadruple nosepiece, deliver high quality ...
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... applications, and the perfect standard system ...
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
Biology Products: